TILT Biotherapeutics was highlighted as one of the key companies developing oncolytic viruses in an interesting report entiteled ” A New Wave of Cancer Therapies: Local Tumor Immuno-Rx Drives Distant Effects”, published by Piper Jaffray & Co.
Latest News
Upcoming Events
Please contact our business development team to meet us at the following events:
8-12th November 2021
Boston (MA, USA)